# Phase 1 sarcoma trials recruiting: 65 (November 2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 65 trials in phase 1 for sarcoma that are recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Recruiting Phase 1 sarcoma trials: 65 rows for $5, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. The new rows each week by email, about 1 row a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/recruiting/phase-1/sarcoma

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 65
- Recruiting or not yet: 65
- Read on: November 19, 2026

## Trials

The 25 newest of 65, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| October 27, 2026 | NCT07897968 | GD2IL18CART Combined With Bevacizumab for Relapsed and Refractory GD2-positive Solid Tumors | Universität Münster | Phase 1 | Not yet recruiting | Neuroblastoma (NBL), Ewing Sarcoma, Osteosarcoma | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07897968) |
| October 22, 2026 | NCT07888114 | Preliminary Clinical Study of Entinostat in Children With Malignant Soft Tissue Sarcoma Harboring PAX-family Gene Abnormalities | Beijing Tongren Hospital | Phase 1 | Recruiting | Soft Tissue Sarcoma | 16 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07888114) |
| August 25, 2026 | NCT07783620 | Treatment of Stage IV Cancer Patients With Multiple Patient-specific Mutated Cell Surface Proteins With Chimeric Antibodies | Centre hospitalier de l'Université de Montréal (CHUM) | Phase 1 | Not yet recruiting | Soft Tissue Cancer | 16 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07783620) |
| August 7, 2026 | NCT07751380 | Multi-modular Chimeric Antigen Receptor T Cells tarGeting B7-H3 in Children, Teenage & Young Adult Sarcoma | University College, London | Phase 1 | Recruiting | Sarcoma | 12 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07751380) |
| July 20, 2026 | NCT07713732 | TLN-499 in Combination With Venetoclax in Patients With Relapsed/Refractory Solid Tumors | Treeline Biosciences, Inc. | Phase 1 | Recruiting | Small Cell Lung Cancer ( SCLC ), Neuroendocrine Cancer, Malignant Pleural Mesotheliomas (Mpm), Synovial Sarcomas | 120 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07713732) |
| July 15, 2026 | NCT07705334 | A Study of SHY-ONC6, a Novel Proteasome Inhibitor, in Adults With Advanced or Metastatic Solid Tumors | SHY Therapeutics | Phase 1 | Recruiting | Advanced or Metastatic Solid Tumors, Triple Negative Breast Cancer (TNBC), HR+ Breast Cancer, Colon Cancer, Gastric... | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07705334) |
| July 10, 2026 | NCT07695311 | EWSR1 Immunotherapy in Ewing Sarcoma and DSRCT | Sponsor not shown (see the record) | Phase 1 | Not yet recruiting | Ewing Sarcoma, Desmoplastic Small Round Cell Tumor | 24 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07695311) |
| June 15, 2026 | NCT07648069 | Tumor Neoantigen Vaccine SarVac Combined With Tumor Specific Lymphocyte Reinfusion in the Treatment of Advanced Sarcoma | Sun Yat-sen University | Phase 1 | Recruiting | Soft Tissue Sarcoma (STS), Osteosarcoma | 16 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07648069) |
| June 5, 2026 | NCT07630961 | Phase I Study of JFI447 \[68Ga\]Ga-DFC413 and Comparison to FFG233 \[68Ga\]Ga-NNS309 in Patients With Solid Tumors | Novartis Pharmaceuticals | Phase 1 | Recruiting | Metastatic Pancreatic Ductal Adenocarcinoma (PDAC), Non-small Cell Lung Cancer (NSCLC), HR+/HER2- Ductal Breast Cancer... | 66 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07630961) |
| May 29, 2026 | NCT07613723 | A Study to Test the Safety, Tolerability and Effect of ZI-MA4-1 for Patients With Locally Advanced or Metastatic Solid Malignancies | Sponsor not shown (see the record) | Phase 1 | Recruiting | Ovarian Cancer, Squamous Non-Small Cell Lung Cancer (NSCLC), Synovial Sarcomas, Head and Neck Cancer | 9 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07613723) |
| March 3, 2026 | NCT07444619 | A Phase I Study of Pazopanib in Combination With Trabectedin, Ipilimumab and Nivolumab (TraPIN) in Pediatric and Young Adult Patients With... | M.D. Anderson Cancer Center | Phase 1 | Recruiting | Soft Tissue Sarcomas | 18 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07444619) |
| January 29, 2026 | NCT07374848 | Phase 1a/b Study of ZL-6201 Safety, PK, and Preliminary Efficacy in Sarcoma and Selected Tumors | Zai Lab (Shanghai) Co., Ltd. | Phase 1 | Recruiting | Solid Tumors, Sarcomas | 180 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07374848) |
| December 22, 2025 | NCT07297979 | Evaluation of Xaluritamig in Adults, Adolescents and Children With Relapsed or Refractory Ewing Sarcoma (EWS) | Amgen | Phase 1 | Recruiting | Ewing Sarcoma | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07297979) |
| December 22, 2025 | NCT07297667 | GCAR1, a Chimeric Antigen Receptor (CAR) T-CELL Therapy for Relapsed/Refractory GPNMB-Expressing Solid Tumours | Canadian Cancer Trials Group | Phase 1 | Recruiting | Alveolar Soft Part Sarcoma, Renal Cell Carcinoma, Triple Negative Breast Cancer | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07297667) |
| December 3, 2025 | NCT07261631 | Phase I Study of \[177Lu\]Lu-DFC413 in Patients With Solid Tumors | Novartis Pharmaceuticals | Phase 1 | Recruiting | Pancreatic Ductal Adenocarcinoma, Non-Small Cell Lung Cancer, HR+/HER2- Ductal and Lobular Breast Cancer, Triple... | 180 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07261631) |
| November 14, 2025 | NCT07229313 | A Study of KIVU-107 in Participants With Locally Advanced or Metastatic Solid Tumors | Kivu Bioscience Inc. | Phase 1 | Recruiting | Advance Solid Tumors | 76 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07229313) |
| October 30, 2025 | NCT07222735 | Hypofractionated Radiation in Combination With B7-H3-CAR T Cells for Pediatric Patients With Relapsed/Refractory Sarcomas | St. Jude Children's Research Hospital | Phase 1 | Recruiting | Sarcoma, Childhood Osteosarcoma, Childhood Rhabdomyosarcoma, Childhood Soft Tissue Sarcoma, Ewing Sarcoma | 42 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07222735) |
| September 29, 2025 | NCT07197554 | A Phase 1/1B Study of ST-01156, a Small Molecule RBM39 Degrader, in Patients With Advanced Solid Malignancies | SEED Therapeutics, Inc. | Phase 1 | Recruiting | Advanced Solid Tumors, Ewing Sarcoma, Hepatocellular Carcinoma (HCC), Biliary Tract Cancer (BTC) | 171 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07197554) |
| September 26, 2025 | NCT07194044 | Metastatic Ewing's Trial Testing Schedule Enhancement to Improve Outcomes | H. Lee Moffitt Cancer Center and Research Institute | Phase 1 | Recruiting | Metastatic Ewing Sarcoma | 15 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07194044) |
| September 15, 2025 | NCT07172958 | Selective Antigen Specific T Cells and CAR T Cells in Subjects With Relapsed/Refractory Embryonal Tumors (SABRE) | Children's National Research Institute | Phase 1 | Recruiting | Rhabdomyosarcoma, Ewing Sarcoma, Neuroblastoma, Wilms Tumor | 18 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07172958) |
| August 24, 2025 | NCT07139990 | Personalized Radiotherapy for Individualized Treatment Strategies and Monitoring (PRISM) | University of Texas Southwestern Medical Center | Phase 1 | Recruiting | Small Cell Lung Cancer Extensive Stage, Brain Metastases, Solid Tumor, Adult, Thoracic Cancer, Sarcoma,Soft Tissue... | 105 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07139990) |
| May 4, 2025 | NCT06957431 | Zanzalintinib Combined With Eribulin in Advanced Liposarcoma and Leiomyosarcoma | Washington University School of Medicine | Phase 1 | Recruiting | Advanced Leiomyosarcoma, Adipocytic Sarcoma, Advanced Liposarcoma | 18 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06957431) |
| April 27, 2025 | NCT06946225 | ACTengine® IMA203 Combined With mRNA-4203 | Immatics US, Inc. | Phase 1 | Recruiting | Cutaneous Melanoma, Synovial Sarcoma | 15 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06946225) |
| April 24, 2025 | NCT06942143 | An Open-label, Phase I Clinical Trial of Super1 TCR-T in NY-ESO-1-positive Patients With Advanced Solid Tumors | Guangzhou FineImmune Biotechnology Co., LTD. | Phase 1 | Recruiting | Sarcoma, Lung Cancers, Melanoma | 15 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06942143) |
| April 13, 2025 | NCT06926283 | A Study of DXC008 in Patients With Prostate Cancer and Other Solid Tumors | Hangzhou DAC Biotechnology Co., Ltd. | Phase 1 | Recruiting | Prostate Cancer, Other Solid Tumors, Ewing Sarcoma | 110 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06926283) |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| National Cancer Institute (NCI) | 5 |
| M.D. Anderson Cancer Center | 3 |
| Memorial Sloan Kettering Cancer Center | 2 |
| St. Jude Children's Research Hospital | 2 |
| [Novartis Pharmaceuticals](https://specstream.ai/data/clinical-trials/company/novartis-pharmaceuticals) | 2 |
| Kura Oncology, Inc. | 1 |
| Mayo Clinic | 1 |
| Lantern Pharma Inc. | 1 |
| Children's Hospital of Philadelphia | 1 |
| SEED Therapeutics, Inc. | 1 |
| GONGCHU Biotechnology Co., Ltd | 1 |
| Inhibrx Biosciences, Inc | 1 |
| ViroMissile, Inc. | 1 |
| Washington University School of Medicine | 1 |
| [Zai Lab (Shanghai) Co., Ltd.](https://specstream.ai/data/clinical-trials/company/zai-lab-shanghai-co-ltd) | 1 |
| [MacroGenics](https://specstream.ai/data/clinical-trials/company/macrogenics) | 1 |
| New York Medical College | 1 |
| [Sorrento Therapeutics, Inc.](https://specstream.ai/data/clinical-trials/company/sorrento-therapeutics-inc) | 1 |
| Sun Yat-sen University | 1 |
| [Amgen](https://specstream.ai/data/clinical-trials/company/amgen) | 1 |
| University College, London | 1 |
| Telix Pharmaceuticals (Innovations) Pty Ltd | 1 |
| Case Comprehensive Cancer Center | 1 |
| University Health Network, Toronto | 1 |
| University of Texas Southwestern Medical Center | 1 |

## By country

| Country | Trials |
| --- | --- |
| United States | 44 |
| China | 7 |
| Australia | 7 |
| United Kingdom | 6 |
| France | 4 |
| Germany | 4 |
| Canada | 3 |
| Japan | 3 |
| Italy | 2 |
| Netherlands | 2 |
| Belgium | 2 |
| Switzerland | 2 |
| Denmark | 2 |
| Spain | 1 |
| Israel | 1 |
| Singapore | 1 |
| South Korea | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Court reporters in the United States](https://specstream.ai/data/businesses/court-reporters/united-states)
- [Tires manufacturers in the United States](https://specstream.ai/data/businesses/tires-manufacturers/united-states)
- [Lighting fixture manufacturers in the United States](https://specstream.ai/data/businesses/lighting-fixture-manufacturers/united-states)
- [Clothing companies in the United States](https://specstream.ai/data/businesses/clothing-companies/united-states)
- [Suppliers and distributors in the United States](https://specstream.ai/data/businesses/suppliers-and-distributors/united-states)
- [IT consultants in the United States](https://specstream.ai/data/businesses/it-consultants/united-states)
